HTA in Baltic countries
Services for the reimbursement applications of pharmaceuticals
and medical devices In Lithuania,
Latvia And Estonia
About Us
Institute of Pharmacoeconomics (based in Kaunas, Lithuania, European Union) is well established partner for market access and reimbursement applications for medicines.
We optimizing patient access to innovative medicines with evidence of value.
We provide evidence-based solutions to demonstrate payers in Baltic States the effectiveness, safety, and economic value of your pharmaceutical and biotechnology products.
We have long-standing health economics, outcomes research, market access, epidemiology, and data analytics professional experience.
We have outstanding knowledge and understanding of payer needs to grant reimbursement and market access for medicines and medical devices.
We provide services in Lithuania, Latvia and Estonia.
Our Services
Reimbursement dossier
preparation
Full service in preparation of reimbursement dossier for medicines, medical devices or medical services.
We can help you in:
- Local data collection and adaptations of global pharmacoeconomic model
- Systematic reviews and meta-analysis
- Indirect treatment comparisons to address gaps between trial and local practice
- Pharmacoecomic modelling
- Data analysis
- Provide overview and analysis of clinical practice in local setting
- Medical writing and communication
- Consultations to address local payer requirements
- Communication with local authorities until reimbursement decisions will be made
We also can provide preliminary assessment of client provided data to adhere decision making needs by local payers.
Evidence Synthesis & Value Story
A coherent and connected value story, supported by strong evidence, must be carefully crafted and presented to grant reimbursement.
While the industry is rich with innovation in pharmaceutical and biotechnology products, health care budgets are scanty. To address budget constrains payers raising requirements for evidence and exploring new payment methods. In order to address payer concerns and achieve favorable and timely drug reimbursement decisions, a reimbursement dossier must be supported by strong evidence, and carefully crafted and presented value story.
We can help you in
- Systematic literature reviews (clinical, economic and utility)
- Meta-analysis
- Evidence synthesis for value dossier
- Data simulations and modelling to forecast unobserved outcomes
- Indirect treatment comparisons
- Exploring value drivers and data gaps
- Measuring comparative effects across therapies
Real-World Evidence & Data Solutions
Evidence of safety, effectiveness, and economic value demonstration is necessary for market access and reimbursement.
We can help you to
- Evaluate country-specific treatment patterns, quantify associated costs of care, and populate health economic models
- Delineate the natural history and course of disease (e.g., incidence, prevalence, standard(s) of care)
- Determine unmet clinical and humanistic needs by characterizing the burden of illness in global and local settings
- Interventional or non interventional study design to address peri- and post-approval needs
- Collect and analyze robust data
- Quantify product-specific and/or comparative safety, effectiveness, treatment patterns, adherence, economic and other outcomes
Medical Writing & Communications
Effective communication of evidence and information is essential to conveying the value of your products to all stakeholders.
We can provide medical writing services for all approval phases of the product lifecycle. We prepare documents that are clear, concise, compelling, and scientifically accurate, while also ensuring they are fully compliant with regulations, best practices, and your corporate guidance.
Reimbursement dossier preparation
Full service in preparation of reimbursement dossier for medicines, medical devices or medical services.
We can help you in:
- Local data collection and adaptations of global pharmacoeconomic model
- Systematic reviews and meta-analysis
- Indirect treatment comparisons to address gaps between trial and local practice
- Pharmacoeconomic modelling
- Data analytics
- Provide overview and analysis of clinical practice in local setting
- Medical writing and communication
- Consultations to address local payer requirements
- Communication with local authorities until reimbursement decisions will be made
We also can provide preliminary assessment of client provided data to adhere decision making needs by local payers.
Evidence Synthesis & Value Story
A coherent and connected value story, supported by strong evidence, must be carefully crafted and presented to grant reimbursement.
While the industry is rich with innovation in pharmaceutical and biotechnology products, health care budgets are scanty. To address budget constrains payers raising requirements for evidence and exploring new payment methods. In order to address payer concerns and achieve favorable and timely drug reimbursement decisions, a reimbursement dossier must be supported by strong evidence, and carefully crafted and presented value story.
We can help you in
- Systematic literature reviews (clinical, economic and utility)
- Meta-analysis
- Evidence synthesis for value dossier
- Data simulations modelling to forecast unobserved outcomes
- Indirect treatment comparisons
- Exploring value drivers and data gaps
- Measuring comparative effects across therapies
Real-World Evidence & Data Solutions
Evidence of safety, effectiveness, and economic value demonstration is necessary for market access and reimbursement.
We can help you to
- Delineate the natural history and course of disease (e.g., incidence, prevalence, standard(s) of care)
- Determine unmet clinical and humanistic needs by characterizing the burden of illness
- Collect and analyze robust data
- Quantify product-specific comparative safety, effectiveness, treatment patterns, adherence, economic and other outcomes
- Evaluate country-specific treatment patterns, quantify associated costs of care and populate health economic models
Medical Writing & Communications
Effective communication of evidence and information is essential to conveying the value of your products to all stakeholders.
We can provide medical writing services for all approval phases of the product lifecycle. We prepare documents that are clear, concise, compelling, and scientifically accurate, while also ensuring they are fully compliant with regulations, best practices, and your corporate guidance.